UROMITEXAN 200MG INJECTION contains
Mesna
, which belongs to a group of medicines called Cytoprotective agents. UROMITEXAN 200MG INJECTION is used to protect the bladder and kidneys from cancer chemotherapy involving cyclophosphamide and ifosfamide as an anticancer medicine.
UROMITEXAN 200MG INJECTION is also used to reduce the risk of bleeding from the bladder when Ifosfamide is used as a chemotherapy drug in affected individuals.
UROMITEXAN 200MG INJECTION is not recommended for use in patients allergic to Mesna.
Before receiving UROMITEXAN 200MG INJECTION, inform your doctor if you have liver problems (such as hepatic impairment), and/or kidney problems (such as renal impairment).
UROMITEXAN 200MG INJECTION is generally not recommended for use during pregnancy and in women planning for pregnancy as it is not known whether the medicine can cause harm to the unborn baby. It is also not recommended for use in breastfeeding women.
UROMITEXAN 200MG INJECTION should be used with caution in children and adolescents (aged below 18 years) only if necessary since it is not known whether the medicine is safe and effective in children. It is also advised to be used with caution in elderly patients (aged 65 years or older) after consulting the doctor.
The most common side effects of taking UROMITEXAN 200MG INJECTION are headaches, dizziness, constipation, flu-like symptoms, sore throat, fever, cough, and/or diarrhea. Consult your doctor if any of these symptoms worsen.
No content available
